Liyuan Zhang

8PUBLICATIONS
26CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Efficacy and safety of combined RANKL and PD-1 inhibitors in bone metastases: a retrospective study.

|May 01, 2026
Citraconate preserves T cell stemness and antitumor immunity.

|Mar 13, 2026
Evaluation of RC48-ADC in Combination with PRaG Regimen: An Open-Label, Prospective, Multicentre Study Assessing Efficacy and Safety for Advanced Refractory HER2-Expressing Solid Tumors (PRaG3.0 Study Protocol).

Meiling Xu, Yuehong Kong, Junjun Zhang

|Jan 22, 2026
Clinical Considerations of Splenic Dose Constraints to Mitigate Radiation-Induced Lymphopenia.

Yifu Ma, Shuying Zhang, Jiayan Ma

|Jan 14, 2026
Circulating T-lymphocyte subsets as biomarkers for immune checkpoint inhibitors in solid tumors.

Yuehong Kong, Rongzheng Chen, Junjun Zhang

|Nov 27, 2025
Efficacy and Safety of PRaG Therapy in Elderly Patients with Advanced Malignant Tumors: A Prospective, Multicenter Clinical Study Protocol (PRaG 9.0 Study).

Xiangrong Zhao, MengMeng Yang, Junjun Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Yifu Ma

1 joint publications

Li Zou

1 joint publications

Wenhui Li

1 joint publications

Minmin Ge